InvestorsHub Logo
Followers 79
Posts 24490
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 04/17/2024 9:12:02 AM

Wednesday, April 17, 2024 9:12:02 AM

Post# of 27395
ABVC - 1.20/1.21 Up from 1.12 Yesterday


ABVC BioPharma Executes A Global Licensing Definitive Agreement For The Treatment Of NSCLC, Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.